Month: April 2014

Glaxosmithkline Recalls Alli

  On March 27, 2014  GlaxoSmithKline (GSK) Consumer Healthcare issued a recall on all alli® weight loss products from U.S. and Puerto Rico retailers due to evidence that some of the packages have been tampered with. Consumers in seven states

Nova Products, Inc. Issues Voluntary Nationwide Recall of Dietary Supplements with Undeclared Active Pharmaceutical Ingredients

On March 27, 2014 Nova Products Inc of Aston, Pennsylvania issued a nationwide recall of  several lots of its natural supplements: African Black Ant (Lot# 2006-000926), Black Ant (Lot# 2006-3627878), XZen Gold (Lot# 130310GL), ZXen Platinum (Lot# 130520PL), XZen 1200

NCPA Seeks Congressional Probe of “Preferred Pharmacy” Part D Plans

The Senate and House Small Business committees should examine the unintended consequences for independent community pharmacies and patients that have resulted from Medicare Part D “preferred pharmacy” prescription drug plans, NCPA told lawmakers last week. “Small business community pharmacies across